PFE logo

Pfizer (PFE) Shareholders equity

annual shareholders equity:

$88.20B-$811.00M(-0.91%)
December 31, 2024

Summary

  • As of today (May 29, 2025), PFE annual stockholders equity is $88.20 billion, with the most recent change of -$811.00 million (-0.91%) on December 31, 2024.
  • During the last 3 years, PFE annual shareholders equity has risen by +$11.00 billion (+14.25%).
  • PFE annual shareholders equity is now -7.80% below its all-time high of $95.66 billion, reached on December 31, 2022.

Performance

PFE Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEbalance sheet metrics

quarterly shareholders equity:

$90.34B+$2.13B(+2.42%)
March 29, 2025

Summary

  • As of today (May 29, 2025), PFE quarterly stockholders equity is $90.34 billion, with the most recent change of +$2.13 billion (+2.42%) on March 29, 2025.
  • Over the past year, PFE quarterly shareholders equity has dropped by -$1.94 billion (-2.11%).
  • PFE quarterly shareholders equity is now -10.53% below its all-time high of $100.97 billion, reached on March 31, 2023.

Performance

PFE quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

PFE Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-0.9%-2.1%
3 y3 years+14.3%+9.6%
5 y5 years+39.7%+38.9%

PFE Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-7.8%+14.3%-10.5%+9.6%
5 y5-year-7.8%+39.7%-10.5%+42.9%
alltimeall time-7.8%+3450.1%-10.5%+3536.1%

PFE Shareholders equity History

DateAnnualQuarterly
Mar 2025
-
$90.34B(+2.4%)
Dec 2024
$88.20B(-0.9%)
$88.20B(-4.4%)
Sep 2024
-
$92.29B(+5.2%)
Jun 2024
-
$87.70B(-5.0%)
Mar 2024
-
$92.28B(+3.7%)
Dec 2023
$89.01B(-6.9%)
$89.01B(-8.2%)
Sep 2023
-
$96.93B(-2.1%)
Jun 2023
-
$99.02B(-1.9%)
Mar 2023
-
$100.97B(+5.5%)
Dec 2022
$95.66B(+23.9%)
$95.66B(+3.3%)
Sep 2022
-
$92.63B(+6.2%)
Jun 2022
-
$87.21B(+5.8%)
Mar 2022
-
$82.42B(+6.8%)
Dec 2021
$77.20B(+22.1%)
$77.20B(+2.0%)
Sep 2021
-
$75.69B(+8.1%)
Jun 2021
-
$70.04B(+2.1%)
Mar 2021
-
$68.62B(+8.5%)
Dec 2020
$63.24B(+0.2%)
$63.24B(-3.1%)
Sep 2020
-
$65.26B(+1.4%)
Jun 2020
-
$64.34B(-1.1%)
Mar 2020
-
$65.03B(+3.0%)
Dec 2019
$63.14B(-0.4%)
$63.14B(-3.0%)
Sep 2019
-
$65.10B(+9.3%)
Jun 2019
-
$59.57B(+1.3%)
Mar 2019
-
$58.81B(-7.3%)
Dec 2018
$63.41B(-11.1%)
$63.41B(-11.1%)
Sep 2018
-
$71.32B(+2.2%)
Jun 2018
-
$69.78B(-0.6%)
Mar 2018
-
$70.18B(-1.6%)
Dec 2017
$71.31B(+19.8%)
$71.31B(+17.3%)
Sep 2017
-
$60.77B(+4.1%)
Jun 2017
-
$58.37B(-0.1%)
Mar 2017
-
$58.44B(-1.9%)
Dec 2016
$59.54B(-8.0%)
$59.54B(-5.9%)
Sep 2016
-
$63.31B(+0.9%)
Jun 2016
-
$62.77B(-0.5%)
Mar 2016
-
$63.07B(-2.6%)
Dec 2015
$64.72B(-9.2%)
$64.72B(-3.2%)
Sep 2015
-
$66.84B(-0.1%)
Jun 2015
-
$66.89B(-0.6%)
Mar 2015
-
$67.30B(-5.6%)
Dec 2014
$71.30B(-6.6%)
$71.30B(-8.6%)
Sep 2014
-
$77.99B(+1.8%)
Jun 2014
-
$76.63B(-1.5%)
Mar 2014
-
$77.77B(+1.9%)
Dec 2013
$76.31B(-6.1%)
$76.31B(-2.1%)
Sep 2013
-
$77.97B(-0.7%)
Jun 2013
-
$78.55B(-4.5%)
Mar 2013
-
$82.25B(+1.2%)
Dec 2012
$81.26B(-1.1%)
$81.26B(-0.5%)
Sep 2012
-
$81.70B(+2.7%)
Jun 2012
-
$79.55B(-4.5%)
Mar 2012
-
$83.26B(+1.3%)
Dec 2011
$82.19B(-6.4%)
$82.19B(-8.7%)
Sep 2011
-
$90.05B(+1.8%)
Jun 2011
-
$88.48B(-1.8%)
Mar 2011
-
$90.07B(+2.6%)
Dec 2010
$87.81B(-2.4%)
$87.81B(+0.2%)
Sep 2010
-
$87.64B(+1.4%)
Jun 2010
-
$86.44B(-3.6%)
Mar 2010
-
$89.66B(-0.4%)
Dec 2009
$90.01B(+56.4%)
$90.01B(+36.1%)
Sep 2009
-
$66.16B(+4.9%)
Jun 2009
-
$63.04B(+4.6%)
Mar 2009
-
$60.26B(+4.7%)
Dec 2008
$57.56B(-11.5%)
$57.56B(-14.5%)
Sep 2008
-
$67.33B(+1.2%)
Jun 2008
-
$66.57B(-1.3%)
Mar 2008
-
$67.42B(+3.7%)
Dec 2007
$65.01B(-8.9%)
$65.01B(-2.4%)
Sep 2007
-
$66.61B(-2.2%)
Jun 2007
-
$68.09B(-6.1%)
Mar 2007
-
$72.49B(+1.6%)
DateAnnualQuarterly
Dec 2006
$71.36B(+8.5%)
$71.36B(+2.4%)
Sep 2006
-
$69.71B(+1.8%)
Jun 2006
-
$68.49B(-1.6%)
Mar 2006
-
$69.61B(+5.8%)
Dec 2005
$65.76B(-3.7%)
$65.76B(-1.6%)
Sep 2005
-
$66.81B(+2.3%)
Jun 2005
-
$65.33B(-3.3%)
Mar 2005
-
$67.53B(-1.1%)
Dec 2004
$68.28B(+4.4%)
$68.28B(-0.2%)
Sep 2004
-
$68.38B(+2.5%)
Jun 2004
-
$66.70B(-3.4%)
Mar 2004
-
$69.05B(+5.6%)
Dec 2003
$65.38B(+227.7%)
$65.38B(-4.6%)
Sep 2003
-
$68.53B(-2.5%)
Jun 2003
-
$70.28B(+182.9%)
Mar 2003
-
$24.84B(+24.5%)
Dec 2002
$19.95B(+9.1%)
$19.95B(+5.3%)
Sep 2002
-
$18.95B(+0.7%)
Jun 2002
-
$18.83B(-4.3%)
Mar 2002
-
$19.67B(+7.5%)
Dec 2001
$18.29B(+13.8%)
$18.29B(-3.2%)
Sep 2001
-
$18.90B(+6.1%)
Jun 2001
-
$17.82B(+0.4%)
Mar 2001
-
$17.75B(+10.4%)
Dec 2000
$16.08B(+15.2%)
$16.08B(-0.6%)
Sep 2000
-
$16.17B(+8.0%)
Jun 2000
-
$14.97B(+47.0%)
Mar 2000
-
$10.19B(-27.0%)
Dec 1999
$13.95B(+58.3%)
$13.95B(+58.8%)
Sep 1999
-
$8.79B(+1.6%)
Jun 1999
-
$8.65B(-4.4%)
Mar 1999
-
$9.04B(+2.7%)
Dec 1998
$8.81B(+11.1%)
$8.81B(+1.9%)
Sep 1998
-
$8.64B(+4.1%)
Jun 1998
-
$8.30B(+1.4%)
Mar 1998
-
$8.19B(+3.2%)
Dec 1997
$7.93B(+14.1%)
$7.93B(+7.1%)
Sep 1997
-
$7.41B(+3.2%)
Jun 1997
-
$7.17B(+0.3%)
Mar 1997
-
$7.15B(+2.8%)
Dec 1996
$6.95B(+26.3%)
$6.95B(+5.9%)
Sep 1996
-
$6.57B(+9.7%)
Jun 1996
-
$5.98B(+1.6%)
Mar 1996
-
$5.89B(+6.9%)
Dec 1995
$5.51B(+27.4%)
$5.51B(+4.3%)
Sep 1995
-
$5.28B(+9.4%)
Jun 1995
-
$4.83B(+2.8%)
Mar 1995
-
$4.70B(+8.6%)
Dec 1994
$4.32B(+11.9%)
$4.32B(+4.1%)
Sep 1994
-
$4.15B(+10.8%)
Jun 1994
-
$3.75B(-2.4%)
Mar 1994
-
$3.84B(-0.7%)
Dec 1993
$3.87B(-18.1%)
$3.87B(+1.1%)
Sep 1993
-
$3.82B(-9.2%)
Jun 1993
-
$4.21B(-5.5%)
Mar 1993
-
$4.45B(-5.6%)
Dec 1992
$4.72B(-6.1%)
$4.72B(-13.7%)
Sep 1992
-
$5.47B(+8.7%)
Jun 1992
-
$5.03B(-0.6%)
Mar 1992
-
$5.06B(+0.7%)
Dec 1991
$5.03B(-1.3%)
$5.03B(-0.9%)
Sep 1991
-
$5.07B(+5.0%)
Jun 1991
-
$4.83B(-6.8%)
Mar 1991
-
$5.18B(+1.7%)
Dec 1990
$5.09B(+12.3%)
$5.09B(+1.6%)
Sep 1990
-
$5.01B(+7.1%)
Jun 1990
-
$4.68B(-1.3%)
Mar 1990
-
$4.74B(+4.5%)
Dec 1989
$4.54B(+5.5%)
$4.54B(+5.5%)
Dec 1988
$4.30B(+10.8%)
$4.30B(+10.8%)
Dec 1987
$3.88B(+13.7%)
$3.88B(+13.7%)
Dec 1986
$3.42B(+16.7%)
$3.42B(+16.7%)
Dec 1985
$2.93B(+17.8%)
$2.93B(+17.8%)
Dec 1984
$2.48B
$2.48B

FAQ

  • What is Pfizer annual stockholders equity?
  • What is the all time high annual shareholders equity for Pfizer?
  • What is Pfizer annual shareholders equity year-on-year change?
  • What is Pfizer quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Pfizer?
  • What is Pfizer quarterly shareholders equity year-on-year change?

What is Pfizer annual stockholders equity?

The current annual shareholders equity of PFE is $88.20B

What is the all time high annual shareholders equity for Pfizer?

Pfizer all-time high annual stockholders equity is $95.66B

What is Pfizer annual shareholders equity year-on-year change?

Over the past year, PFE annual stockholders equity has changed by -$811.00M (-0.91%)

What is Pfizer quarterly stockholders equity?

The current quarterly shareholders equity of PFE is $90.34B

What is the all time high quarterly shareholders equity for Pfizer?

Pfizer all-time high quarterly stockholders equity is $100.97B

What is Pfizer quarterly shareholders equity year-on-year change?

Over the past year, PFE quarterly stockholders equity has changed by -$1.94B (-2.11%)
On this page